The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

SGLT2 diabetes meds like Jardiance or Farxiga do the same ... Both are risk factors for heart attack and stroke. “Another ...

New study reports protective effect among people with type 2 diabetes Kidney stones and the systemic conditions associated with them have a major impact on health and the economy in the US and ...

A recent case report highlights the importance of understanding the possibility of the development of Euglycemic diabetic ...

Further studies could explore the mechanisms underlying this gender-specific response ... Cardiovascular risks with sglt2 ...

Prioritise Protein Intake: Aiming for a daily protein intake of about 1.2–2 grams per kilogram of body weight is generally ...

Of note, a similar proportion of patients in the empagliflozin and placebo groups (43% and 40%, respectively) were using an ...

Patients with broad range of kidney function show reduced effects following discontinuation after EMPA-KIDNEY trial.

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on ...